CD molecules (ligands)

Mouse anti Human Thrombomodulin Antibody, Monoclonal (H6), could be used for WB and so on.ApplicationWB: 0.01-2 μg/mLProtein FunctionThrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichiometric complex with thrombin. This

Mouse anti Human Thrombomodulin Antibody, Monoclonal (H6), could be used for WB and so on.ApplicationWB: 0.01-2 μg/mLProtein FunctionThrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichiometric complex with thrombin. This

Mouse anti Human Thrombomodulin Antibody, Monoclonal (H6), could be used for WB and so on.ApplicationWB: 0.01-2 μg/mLProtein FunctionThrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichiometric complex with thrombin. This

Mouse anti Human Thrombomodulin Antibody, Monoclonal (H6), could be used for WB and so on.ApplicationWB: 0.01-2 μg/mLProtein FunctionThrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichiometric complex with thrombin. This

Vofatamab (anti-FGFR3) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab (anti-FGFR3) blocks activation of both the wildtype and genetically activated receptor. Vofatamab (anti-FGFR3) can be used in the research of metastatic urothelial

Vofatamab (anti-FGFR3) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab (anti-FGFR3) blocks activation of both the wildtype and genetically activated receptor. Vofatamab (anti-FGFR3) can be used in the research of metastatic urothelial

Vofatamab (anti-FGFR3) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab (anti-FGFR3) blocks activation of both the wildtype and genetically activated receptor. Vofatamab (anti-FGFR3) can be used in the research of metastatic urothelial

Vofatamab (anti-FGFR3) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab (anti-FGFR3) blocks activation of both the wildtype and genetically activated receptor. Vofatamab (anti-FGFR3) can be used in the research of metastatic urothelial